| Product Code: ETC9514167 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import of interferons in 2024 saw a significant increase in concentration, with top exporting countries being Peru, Netherlands, USA, Brazil, and Germany. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, which intensified in 2024. Despite a modest compound annual growth rate (CAGR) of 2.08% from 2020 to 2024, there was a notable decline in growth rate (-8.75%) from 2023 to 2024. This suggests a shifting landscape in the interferons market in Suriname, potentially influenced by various factors impacting import trends.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Interferons Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Interferons Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Interferons Market - Industry Life Cycle |
3.4 Suriname Interferons Market - Porter's Five Forces |
3.5 Suriname Interferons Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Interferons Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Suriname Interferons Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Suriname Interferons Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Suriname Interferons Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Interferons Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases that can be treated with interferons in Suriname |
4.2.2 Growing awareness and adoption of advanced medical treatments in the country |
4.2.3 Government initiatives to improve healthcare infrastructure and access to innovative therapies |
4.3 Market Restraints |
4.3.1 High cost of interferon therapy leading to affordability issues for patients |
4.3.2 Limited availability and accessibility of specialized healthcare facilities in Suriname |
4.3.3 Stringent regulatory requirements for approval and use of interferon treatments in the market |
5 Suriname Interferons Market Trends |
6 Suriname Interferons Market, By Types |
6.1 Suriname Interferons Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Interferons Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Interferons Market Revenues & Volume, By Alpha, 2021- 2031F |
6.1.4 Suriname Interferons Market Revenues & Volume, By Beta, 2021- 2031F |
6.1.5 Suriname Interferons Market Revenues & Volume, By Gamma, 2021- 2031F |
6.1.6 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Interferons Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Suriname Interferons Market Revenues & Volume, By Chronic Hepatitis, 2021- 2031F |
6.2.3 Suriname Interferons Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.2.4 Suriname Interferons Market Revenues & Volume, By AIDS, 2021- 2031F |
6.2.5 Suriname Interferons Market Revenues & Volume, By Kaposi Sarcoma, 2021- 2031F |
6.2.6 Suriname Interferons Market Revenues & Volume, By Malignant Melanoma, 2021- 2031F |
6.2.7 Suriname Interferons Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.8 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Interferons Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Suriname Interferons Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.3 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Suriname Interferons Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Suriname Interferons Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Suriname Interferons Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Suriname Interferons Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Suriname Interferons Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Suriname Interferons Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Suriname Interferons Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Suriname Interferons Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Suriname Interferons Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Suriname Interferons Market Import-Export Trade Statistics |
7.1 Suriname Interferons Market Export to Major Countries |
7.2 Suriname Interferons Market Imports from Major Countries |
8 Suriname Interferons Market Key Performance Indicators |
8.1 Patient adherence rate to interferon therapy |
8.2 Number of healthcare facilities offering interferon treatments in Suriname |
8.3 Rate of government funding allocated to healthcare infrastructure development in the country |
9 Suriname Interferons Market - Opportunity Assessment |
9.1 Suriname Interferons Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Interferons Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Suriname Interferons Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Suriname Interferons Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Suriname Interferons Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Interferons Market - Competitive Landscape |
10.1 Suriname Interferons Market Revenue Share, By Companies, 2024 |
10.2 Suriname Interferons Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here